CONTEXT
- The incorporation of best practice guidelines into one's institution is a challenging goal of utilization management, and the successful adoption of such guidelines depends on institutional context. Laboratorians who have access to key clinical data are well positioned to understand existing local practices and promote more appropriate laboratory testing.
OBJECTIVE
- To apply a novel approach to utilization management by reviewing international clinical guidelines and current institutional practices to create a reliable mechanism to improve detection and reduce unnecessary tests in our patient population.
DESIGN
- We targeted a frequently ordered genetic test for HFE-related hereditary hemochromatosis, a disorder of low penetrance. After reviewing international practice guidelines, we evaluated 918 HFE tests and found that all patients with new diagnoses had transferrin saturation levels that were significantly higher than those of patients with nonrisk genotypes (72% versus 42%; P < .001).
RESULTS
- Our "one-button" order that restricts HFE genetic tests to patients with transferrin saturation greater than 45% is consistent with published practice guidelines and detected 100% of new patients with HFE-related hereditary hemochromatosis.
CONCLUSIONS
- Our proposed algorithm differs from previously published approaches in that it incorporates both clinical practice guidelines and local physician practices, yet requires no additional hands-on effort from pathologists or clinicians. This novel approach to utilization management embraces the role of pathologists as leaders in promoting high-quality patient care in local health care systems.
[1]
Catherine Pope,et al.
Thou shalt versus thou shalt not: a meta-synthesis of GPs' attitudes to clinical practice guidelines.
,
2007,
The British journal of general practice : the journal of the Royal College of General Practitioners.
[2]
D. Swinkels,et al.
EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH)
,
2015,
European Journal of Human Genetics.
[3]
G. Paré,et al.
Examining the clinical use of hemochromatosis genetic testing.
,
2015,
Canadian journal of gastroenterology & hepatology.
[4]
Jacquelyn D. Riley,et al.
Improving Molecular Genetic Test Utilization through Order Restriction, Test Review, and Guidance.
,
2015,
The Journal of molecular diagnostics : JMD.
[5]
Alison B. Hamilton,et al.
Electronic health record interventions at the point of care improve documentation of care processes and decrease orders for genetic tests commonly ordered by nongeneticists
,
2016,
Genetics in Medicine.
[6]
J. Koziol,et al.
Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA
,
2002,
The Lancet.
[7]
E. Livesey,et al.
Implementing guidelines: what works
,
2007,
Archives of disease in childhood - Education & practice edition.
[8]
Anand S Dighe,et al.
The role of informatics and decision support in utilization management.
,
2014,
Clinica chimica acta; international journal of clinical chemistry.